Tregs limit the CD80/CD86–CD28-dependent activation of T cells through CTLA-4-dependent downregulation of CD80 and CD86 expression on DCs (Sakaguchi et al., 2020), which may contribute to the reduction in atherosclerosis (Matsumoto et al., 2016). This evidence concerns the gene CD80 and atherosclerosis.